MedPath

Cost- Effectiveness Study of Brief Interventions for Mood and Anxiety Disorders

Not Applicable
Completed
Conditions
Depressive Disorder
Anxiety Disorder
Registration Number
NCT01643642
Lead Sponsor
Leiden University Medical Center
Brief Summary

This study compares both clinical effectiveness and cost-effectiveness of a brief, intensified therapy and diagnostic method for patients with mood and/or anxiety disorders with Treatment As Usual (TAU) at five outpatient Mental Healthcare Centers in the Netherlands.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
182
Inclusion Criteria
  • Male of female adolescents
  • Adolescents aged between 18 to 65 year
  • Adolescents main complaint: Mild to moderate anxiety and/or mood disorders with or without psychiatric and/or somatic co-morbidity
  • Adolescents with proper understanding of the Dutch language.
Exclusion Criteria
  • Adolescents with current psychotic or bipolar traits,
  • Adolescents with homicidal or suicidal risk
  • Adolescents with severe social disfunctioning
  • No proper understanding of the Dutch language

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Effectiveness of the interventionapproximately 3 years (start: march 2010).

Effectiveness of the intervention is investigated by the main questionnaires: Web Screening Questionnaire (WSQ) and Brief Symptom Inventory (BSI) as conducted by ROM

Secondary Outcome Measures
NameTimeMethod
Cost-effectiveness interventionapproximately 3 years (start: march 2010).

Cost-effectiveness is explored by an open questionnaire Trimbos/iMTA Questionnaire for Cost Associated with Psychiatric Illness (TIC-P).

Additionally patient and therapist satisfaction about the intervention is explored.

Trial Locations

Locations (1)

Rivierduinen

🇳🇱

South Holland, Netherlands

Rivierduinen
🇳🇱South Holland, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.